STELARA ® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, August 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). This rare disease that resembles adult PsA affects five to eight percent of children and adolescents with chronic inflammatory arthritis.*1-7 Two of the four indications for STELARA now include pediatric patients, further expanding its treatment profile since the first approval in 2009 for adults living with moderate...
Source: Johnson and Johnson - August 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
FDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis FDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis
A topical formulation of a PDE4 inhibitor approved for treating COPD has been approved for treatment of plaque psoriasis.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 30, 2022 Category: Dermatology Tags: Dermatology News Alert Source Type: news
FDA Approves Zoryve (roflumilast) Cream for the Treatment of Plaque Psoriasis
WESTLAKE VILLAGE, Calif., July 29, 2022 (GLOBE NEWSWIRE)— Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced today... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 29, 2022 Category: Drugs & Pharmacology Source Type: news
Psoriasis Questionnaire Might Identify Risk of Axial Disease Psoriasis Questionnaire Might Identify Risk of Axial Disease
A patient-completed questionnaire shows promise for detecting risk of undiagnosed axial involvement in psoriasis.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 26, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
NAFLD Strongly Correlated With Psoriasis, PsA NAFLD Strongly Correlated With Psoriasis, PsA
The 11 observational studies included in the meta-analysis met stringent criteria, including a diagnosis of psoriasis and PsA based on objective criteria, and NAFLD confirmed with liver biopsy or imaging.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 22, 2022 Category: Consumer Health News Tags: Dermatology News Source Type: news
AI System Could Help Clinicians Assess Psoriasis Severity
THURSDAY, July 21, 2022 -- An artificial intelligence (AI) system could aid clinicians in assessing psoriasis severity, according to a short report published online June 28 in the Journal of the European Academy of Dermatology and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2022 Category: Pharmaceuticals Source Type: news
Smoking Is Causally Associated With Psoriasis Risk
WEDNESDAY, July 20, 2022 -- Smoking, but not alcohol consumption, is causally associated with psoriasis, according to a study published online June 28 in the British Journal of Dermatology.
Jiahe Wei, from Hangzhou Medical College in China, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2022 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Reports Q2 2022 Results
New Brunswick, N.J. (July 19, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2022. “Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, Chief Executive Officer. “I am continually energized by the focus and passion of my Johnson & Johnson colleagues and their dedication toward delivering transformative healthcare solutions to patients and consumers around the world.”OVERALL FINANCIAL RESULTS
expand
...
Source: Johnson and Johnson - July 19, 2022 Category: Pharmaceuticals Tags: Financial Source Type: news
Tapinarof Effective for Longer-Term Treatment of Plaque Psoriasis
WEDNESDAY, July 13, 2022 -- Four in 10 plaque psoriasis patients achieve complete disease clearance with tapinarof cream, 1 percent, according to a study published online June 26 in the Journal of the American Academy of Dermatology.
Bruce Strober,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2022 Category: Pharmaceuticals Source Type: news
Picture of Psoriasis Vulgaris Plaque
Title: Picture of Psoriasis Vulgaris PlaqueCategory: ImagesCreated: 2/24/2010 11:08:00 AMLast Editorial Review: 7/13/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - July 13, 2022 Category: Dermatology Source Type: news
Cohort Study Evaluates Risk of TNF Inhibitor –Induced Psoriasis Cohort Study Evaluates Risk of TNF Inhibitor –Induced Psoriasis
The study involved an analysis of TNF inhibitor-induced psoriasis risk in 109,085 patients with RA and IBD enrolled in Danish national registries between 1995 and 2018.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 11, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Halobetasol Propionate Lotion for Plaque Psoriasis Halobetasol Propionate Lotion for Plaque Psoriasis
Review the use of Bryhali, a novel, super-potent topical corticosteroid lotion which has been approved for plaque psoriasis and certain corticosteroid-responsive dermatoses.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 11, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Should Self-help Interventions Be Routine in Psoriasis Therapy? Should Self-help Interventions Be Routine in Psoriasis Therapy?
A new study examined the impact of online compassion-focused self-help for psoriasis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 11, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
CBD and Cannabis Products for Acne, Psoriasis? Buyer Beware
Many turn to CBD and cannabis products to treat a variety of skin conditions. But researchers warn that the science on their safety and power hasn't kept up with demand. (Source: WebMD Health)
Source: WebMD Health - July 7, 2022 Category: Consumer Health News Source Type: news
Episode 5: Psoriasis Oral Agents: What to Know to Prescribe Like a Pro Episode 5: Psoriasis Oral Agents: What to Know to Prescribe Like a Pro
This podcast has the goods on what oral therapy to recommend for almost any circumstance, even weddings. Drs Steven Feldman and Bruce Strober share a treasure trove of practical wisdom.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2022 Category: Consumer Health News Tags: Dermatology InDiscussion Source Type: news
